Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-3

Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting it Right?

Wesley D. Kufel, Robert W. Seabury, William Darko [...]

Hospital Pharmacy

Retricted access

Research article

First published 2019-8

Comparing Anti–Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin

Rebekah A. Wahking, Rachel H. Hargreaves, Sean M. Lockwood [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2010-6

Stability of Plasma Anti-Xa Activity in Low-Molecular-Weight Heparin Monitoring

Ponlapat Rojnuckarin, Benjaporn Akkawat, Jumlong Juntiang

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2004-10

Anti-Xa Monitoring of Enoxaparin for Acute Coronary Syndromes in Patients with Renal Disease

Jessica M Ma, Cynthia A Jackevicius, Erik Yeo

Annals of Pharmacotherapy

Free access

Research article

First published 2003-2

Anti-factor Xa Monitoring of Anticoagulation during Cardiopulmonary Bypass in a Patient with Antiphospholipid Syndrome

M. J. Lennon, N. M. Thackray, N. M. Gibbs

Anaesthesia and Intensive Care

Open access

Research article

First published 2024

Anti-Xa Monitoring of Apixaban (ZyQuis) in Venous Thrombo-Embolism and Atrial Fibrillation

Elise Schapkaitz, Byron Ter Morshuizen, Melanie Mc Cree [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2021

Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury

William Towers, Steffany N. Nguyen, Melanie C. Ruegger [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2004-10

Anti-Xa and Anti-IIa Drugs Alter International Normalized Ratio Measurements: Potential Problems in the Monitoring of Oral Anticoagulants

Mahmut Tobu, Omer Iqbal, Debra Hoppensteadt [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2024

Anti-Xa Activity Monitoring for Optimizing Rivaroxaban Dosage in Chinese Patients with Cerebral Venous Thrombosis

Xiaoming Zhang, Meini Gao, Duo Lan [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2018-3

Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms

Emily Whitman-Purves, James C. Coons, Taylor Miller [...]

Clinical and Applied Thrombosis/Hemostasis

Search results